CRISPR Cas9 Market and Patent Landscape Analysis Report

Posted by Divya Rathi on February 22nd, 2019

Patent Landscape Analysis and Market Research Report onCRISPR Cas9 aims to present the key market insights and patent landscape for the for the technology which drive the innovation scene in the CRISPR Cas9 tools market for genome editing. And it also aims to analyse the current market dynamics and prospective future developments to present an accurate business and patent landscape for CRISPR-Cas9 technology to assist the readers in a realistic quantitative and qualitative analyses of the industry.

This report focus on the segmentation of CRISPR-Cas9 market by Applications (academic research tools, drug development, agriculture, human clinical therapeutics, and animal and disease model). By Products (editing tools, cell lines, animal models, and plant breeding products ). By Regional segmentation into North America, Europe, Asia Pacific (APAC) and Rest of World (RoW). By Technology (Drug Compound and Target Screening, and Agriculture And Nutritional Health Products ) and in-depth analysis of global Crispr-Cas9 market, forecasts and key players is intended to aid the researchers in understanding global opportunities in this space.

The global market for CRISPR-Cas9 technology was estimated at ,220 million in 2017 which is projected to grow exponentially at a CAGR of 20.19 per cent and attain a market value of ,311 million by 2025. Various market segments such as therapeutics, research tools, drug discovery and agriculture have been evaluated on the bases of emerging growth opportunities. Market driving factors and constraints have been considered to estimate global CRISPR Cas9 market potential.

CRISPR-Cas9 is becoming a pre-requisite tool in genome editing market. The programmable capacity of the Cas9 enzyme is now transforming varied fields of medical research, industrial and animal biotechnology, and agriculture. CRISPR-Cas9 gene editing technology is an immensely stimulating area for molecular biologists, opening a wide range of opportunities in several application areas.

CRISPR Cas9 market report also covers the patent trends in detail to understand the research and development activities happening around the world over the years. It delves into licensing and litigation battles which are restricting the commercial growth of the market. this report will delve deep into the patent landscape for this disruptive technology identifying key patent assignees and inventors. It will also highlight academic and corporate collaborations, and litigation and licensing environment.

CRISPR-Cas9 patent landscape is dominated by universities and research institutes over commercial companies. US and Chinese academic institutions are actively pursuing research activities in CRISPR domain. Massachusetts Institute of Technology (MIT) holds the largest patent portfolio in CRISPR-Cas9 technology with 103 IP assets. Several new Chinese players like Univ China Agricultural, Univ Shanghai Jiao Tong, Univ Northwest A&F, and Inst Genetics & Developmental Biology, CAS have been key applicants from 2015 onwards.

To know more visit – CRISPR Cas9 Market Report